View in EDS HTML Full Text PDF Full Text

PEGylated thymosin β4 is a thiol‐site‐specific prodrug treating myocardial infarction in vivo.

Saved in:
Bibliographic Details
Title: PEGylated thymosin β4 is a thiol‐site‐specific prodrug treating myocardial infarction in vivo.
Authors: Peng, Haisheng1 (AUTHOR), Chai, Yanqun2 (AUTHOR), Gong, Chen2 (AUTHOR), Hao, Yue1,3 (AUTHOR), Peng, Yanbo4 (AUTHOR), Zhang, Wenyuan2 (AUTHOR), Liu, Xiaoying2 (AUTHOR), Tang, Shukun2 (AUTHOR), Kong, Qingfei3 (AUTHOR) kqfangel@hrbmu.edu.cn, Wang, Qun5 (AUTHOR) qunwang@iastate.edu
Source: Bioengineering & Translational Medicine. Jul2026, Vol. 11 Issue 4, p1-16. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:23806761
DOI:10.1002/btm2.70144